Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Avandia receives FDA approval for treatment of type II diabetes

May 26, 1999

News from APA: bupropion SR suggested to hold promise as an antiobesity treatment

May 26, 1999

Alteon to seek new partner for continued pimagedine development

May 25, 1999

Axcan's Protectaid contraceptive sponge approved in Italy

May 25, 1999

L-770644: potent and selective human beta3-adrenoceptor agonist with good oral bioavailability

May 25, 1999

Merck closes in on oral oxytocin antagonist for use in preterm labor

May 25, 1999

Novel series from Dr. Reddy for diabetes, hyperlipidemia, etc.

May 25, 1999

Novel epoxysuccinamide derivatives for bone diseases/arthritis developed at Nippon Chemiphar

May 25, 1999

Merck researchers describe L-783281, a novel antidiabetic agent of fungal origin

May 24, 1999

Vivus signs registration and marketing agreement in Japan for Muse

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...